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ABSTRACT

REGULATION OF ADRENAL STEROIDOGENESIS BY INTERLEUKIN-6

Stephen A. McIlmoil
Physiology and Developmental Biology
Master of Science

Cortisol and dehydroepiandrosterone (DHEA) are steroids produced by the zona
fasciculata (ZF) and reticularis (ZR), respectively, of the adrenal cortex. Both steroids
are upregulated in response to adrenocorticotropic hormone (ACTH). Cortisol is a
glucorticoid that is important in the regulation of inflammation and metabolism. DHEA
is an adrenal androgen important in fetal growth and puberty but tends to decrease
gradually after puberty in both men and women. DHEA has various effects on
metabolism and immune function including inhibiting the effects of cortisol on some
tissues.
During the acute phase of stress, cortisol and DHEA rise due to an increase in
ACTH released from the anterior pituitary. In contrast, during chronic stress, cortisol
remains elevated but DHEA and ACTH levels decrease. Likewise, stress causes serum
levels of IL-6 to increase. IL-6 increases cortisol release from the human and bovine
adrenal cortex. IL-6 also decreases DHEA release from zona reticularis of the bovine
adrenal gland. In humans the effect of IL-6 on DHEA production is still uncertain.
To determine a possible mechanism of IL-6 on the zona fasciculata and
reticularis, human H294R cells and bovine adrenal tissue were incubated in serum free

medium containing IL-6, at various concentrations and incubation intervals. At the end
of the incubation interval, mRNA or protein was extracted from the cells or tissue.
Standard PCR, real time PCR, and western blot assays were used to determine the effects
of IL-6 on the enzymes involved in cortisol and DHEA synthesis, steroidogenic factor-1
(SF-1), steroidogenic acute regulatory protein (StAR), and dosage sensitive sex reversal
adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX-1).
In human H295R cells and bovine zona fasciculata cells IL-6 caused an increase
in SF-1, StAR, P450scc, 17α hydroxylase, 3β-hydroxysteroid dehydrogenase type 2 (3β
HSD2), 21 hydroxylase, and 11β hydroxylase mRNA and protein. IL-6 caused DAX-1
mRNA and protein to decrease. These effects were manifest in a time dependent manner.
Dose response treatments incubated for 60 min increased SF-1, StAR, P450scc, 17α
hydroxylase, 3β HSD2, 21 hydroxylase, and 11β hydroxylase but there was not
significant change between the different treatments of IL-6. The bovine zona reticularis
stimulated with IL-6 showed a decrease in SF-1, StAR, P450scc, 17α hydroxylase, and
3β HSD2 with an increase in DAX-1 mRNA and protein. This response was manifest in
a time dependent manner for both mRNA and protein, and the effect was dose-dependent
for mRNA but not protein levels within the 60 min time period. These data provide a
mechanism by which increased stress, physical or emotional, which increases IL-6 serum
level, could increase cortisol and decrease DHEA. This would account for decreased
immune function, increased blood pressure, and changes in metabolism.
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Introduction
Glucocorticoids are steroid hormones that regulate serum glucose levels.
Cortisol is the main glucocorticoid produced by the body. Cortisol is released from
the zona fasciculata of the adrenal cortex during stress and is derived from
cholesterol. Cortisol affects many different tissues and processes of the body. Some
effects of cortisol include 1) decreasing the number of circulating lymphocytes 2)
inhibiting T-cell activation and maturation 3) increasing gluconeogenesis, protein
breakdown, and increasing amino acids in the blood and fatty acid liberation 4)
increasing blood pressure by causing vasoconstriction due to an increase in alpha
adrenergic receptors 5) increasing renal blood flow and glomerular filtration rate 6)
increasing Na+ reabsorption by the collecting duct 7) decreasing water absorption 8)
decreasing bone formation rate and increasing demineralization (25).
Cortisol is produced by conversion of cholesterol to the active steroid.
Cholesterol is made available for conversion to steroids by adrenal via endocytosis of
a low density lipoprotein (LDL) (26), synthesis of cholesterol by the adrenal (27),
selective cellular uptake (27), stored cholesterol esters inside the adrenal (26), and
scavenger receptors (28). Intercellular cholesterol that will be used in
steroidogenesis is transported from the cytosol to the intermembrane space of the
mitochondria by the steroidogenic acute regulatory protein (StAR) (24). In the
mitochondria the side chain of cholesterol is cleaved, by cytochrome P450 side chain
cleavage enzyme (P450scc or desmolase), producing pregnenolone. Pregnenolone
then leaves the mitochondria, entering cytoplasm, where it is converted to
progesterone in the by 3β hydroxysteroid dehydrogenase type 2 (3β HSD2).
Progesterone, in the endoplasmic reticulum, is enzymatically converted by 17α
hydroxylase (P450c17) to 17OH-progesterone. Further modifications then happen in
the endoplasmic reticulum by adding a hydroxyl group to the 21 carbon by 21
hydroxylase (P450c21). The final step of cortisol production occurs in the
mitochondria, where the 11 carbon is hydroxylated by 11β hydroxylase (P450c11β)
(18) (Diagram 1).
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The traditional pathway of stimulation of cortisol production is through
corticotrophin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH).
CRH is released from the hypothalamus which enters the hypophyseal portal system
via capillary beds in the median eminence, travels through the blood down the long
portal veins, and enters the anterior pituitary where it acts on corticotrophs causing
the release of ACTH. ACTH then enters the blood stream and flows to the adrenal
where it binds to a seven transmembrane receptor. This receptor, when activated by
ACTH, causes the activation of a G-protein, Gs. Gs, then activates adenylyl cyclase
and cAMP is produced. cAMP binds to regulatory subunits of PKA which activates
the kinase (30). PKA phosphorylates proteins such as hormone sensitive lipase
(HSL) (29) and cAMP response element binding protein (CREB). Phosphorylated
CREB translocates to the nucleus and causes transcription (31). Through these
actions, cortisol is produced.
Acute stress causes a rise in ACTH and therefore, cortisol. During chronic
stress, the concentration of ACTH does not correspond to the concentration of
cortisol (13). Therefore, other hormones or cytokines must be causing the elevated
cortisol levels. One cytokine that has been shown to cause cortisol secretion is
interleukin-6 (IL-6) (10). IL-6 is produced by many tissues in the body including
activated T-cells, monocytes, fibroblasts, endothelial cells, macrophages and skeletal
muscle. It is also produced by the zona glomerulosa of the rat adrenal and all zones
of the human and bovine adrenal cortex (10). IL-6 produced by the adrenal could
have a paracrine effect on the adrenal affecting the zona fasciculata. The adrenal
cortex has been shown to increase IL-6 production when stimulated by IL-1α, IL-1β,
TNFα, ACTH, and angiotensin II (10).
Dehydroepiandrosterone (DHEA) is an androgen produced and released from
the zona reticularis of the adrenal cortex. ACTH has been shown to increase the
production of DHEA in healthy human subjects (19). IL-6 has been shown to cause a
decrease in the basal level and ACTH stimulation of DHEA production in bovine
adrenal cells (20). DHEA is thought of as a prohormone. DHEA is secreted in large
amounts and is converted to sex steroids locally in the tissue. In this manner the
tissue can regulate the amount of steroid and when it will be stimulated by the steroid
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in a precise manner. DHEA indirectly effects bone formation, adipose tissue, muscle,
insulin and glucose metabolism, skin, and libido (23).
The IL-6 regulation of steroidogenesis in the adrenal cortex is thought to be
mediated by the janus kinase (JAK) system (unpublished observation). In other
tissues, IL-6 effects are mediated through the JAK-STAT (signal transducers and
activator of transcription protein) pathway. Some of these effects include increased
body temperature and regulation of inflammation. The JAK associated with the IL-6
receptor is a serine-threonine kinase. When IL-6 binds to the receptor, the receptor
dimerizes and JAK phosphorylates the cytoplasmic tails of the IL-6 gp130 subunit.
JAK subunits are auto-phosphorylated when IL-6 binds to the receptor. When the
JAK is phosphorylated, STATs bind near the phosphate group on the gp130 subunits
and are phosphorylated by JAK. Phosphorylated STATs then dimerize. Dimerized
STATs move to the nucleus and cause the transcription of genes. The dimerized
STATs can be homo- or hetero-dimers (14, 21).
CREB and the STATs are nuclear factors. Nuclear factors are proteins which
regulate the rate of transcription of genes. STATs are involved in steroidogenesis in
bovine luteal cells (15). CREB is involved in the regulation of genes but the role of
CREB in steroidogenesis is uncertain. It has been suggested that the acute phase 1
proteins (AP-1), specifically cFos and cJun, play a larger role and cooperate with
steroidogenic factor-1 (SF-1) to cause transcription of cytochrome P450 side chain
cleavage enzyme (16). SF-1 has also been shown to be important for steroidogenesis
in many tissues. While SF-1 up-regulates transcription of steroidogenic components,
DAX-1 (Dosage sensitive sex reversal – adrenal hypoplasia congenita gene on the X
chromosome, gene 1) has an opposing effect (3). DAX-1 is a nuclear factor which
suppresses transcription. In mouse adrenal cells Dax-1 inhibits StAR and decreases
P450scc and 3β HSD2 promoter activity (17).
IL-6 increases cortisol production in bovine ZF cells and human H295R cells,
but decreases DHEA production in bovine ZR cells (20). This paradoxical effect of
IL-6 on steroidogenesis raises the question: how does IL-6 increase and decrease
steroidogenesis in two tissues that are very similar? The tissue and cells used in this
study were bovine zona fasciculata, zona reticularis, and human H295R cells. IL-6
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was used in a dose and time dependent manner to study its effect on mRNA and
protein levels of the nuclear factors DAX-1 and SF-1 and the enzymes involved in
cortisol production, P450scc, 17α hydroxylase, 3β HSD2, 21 hydroxylase, and 11β
hydroxylase in bovine zona fasciculata and human H295R adrenal cells; and mRNA
and protein levels for the nuclear factors DAX-1 and SF-1 and the enzymes involved
in androgen production P450scc, 17α hydroxylase, and 3β HSD2 in bovine zona
reticularis adrenal cells.
Materials and Methods
Media
DMEM/F12
The DMEM/F12 was purchased from GIBCO as a powder. Water and
NaHCO3 were added to the DMEM/F12 powder as outlined by the instructions that
come with the powdered medium. The media was then filter sterilized using vacuum
filters inside of a sterile hood. The medium was completed by addition of New Calf
Serum (purchased from HyClone), penicillin-streptomycin (purchased from GIBCO),
and insulin-transferrin-sodium selenite (ITS). For completion of 500 ml of
DMEM/F12 medium 26.5 ml of New Calf serum, 4.25 ml of penicillin-streptomycin,
and 530 µl of ITS was added. Completion of medium was done only when needed
and only 500ml were completed at one time. The complete and incomplete
DMEM/F12 was stored in the refrigerator between 0° – 4° C.
RPMI
RPMI medium 1640 was purchased from GIBCO in powder form. The
powder was mixed with sterile water and NaHCO3 at room temperature. The solution
was mixed using a magnetic stir bar until the powder was completely dissolved. The
RPMI was then filter sterilized using a vacuum filter in a sterile hood. The RPMI
1640 medium was kept in a refrigerator at a temperature of 0° – 4° C. 500 ml of
RPMI was completed by addition of fetal calf serum, horse serum, and 150 µl of a
mixed solution containing penicillin – G (Sigma), streptomycin (Sigma), gentamicin
(Sigma), and amphotericin – B (Sigma). The mixture of antibiotics and antifungal
4

had a volume of 8 ml and contained 200 mg penicillin – G, 200 mg streptomycin, 15
mg amphotericin – B, and 400 mg gentamicin. 8 ml of distilled sterile water was
added to the antibiotics and antifungal and then vortexed. RPMI was completed only
when needed.
H295R cultured cells
H295R cells were incubated in DMEM/F12 complete medium. Five ml of
DMEM/F12 complete was added to every 100 mm culture plate. The H295R cells
were grown on the plates in an incubator set to 5% CO2. Once the cells were 70-80%
confluent they were used in the experiment.
Bovine Adrenal Fragments
Bovine adrenal glands were collected from the abattoir. The Adrenals were
collected and placed in sterile 1X phosphate buffer solution (PBS) soon after the cow
was killed. They were brought back to the laboratory where they were sliced and
dissected into the different zones; ZF and ZR. Once the zones were separated they
were cut into small fragments and used for an experiment the same day. Medium
used for the bovine tissue treatments was RPMI incomplete containing IL-6 in
picogram concentrations.
Time Course Experiments
Human Time Course
Cultured H295R cells were incubated with DMEM/F12 incomplete that
contained 50 pg/ml of IL-6. The plates were placed in an incubator with 5% CO2 for
the duration of the treatment. Each plate of cells was incubated for a different
amount of time. Incubation time ranged from 0 – 240 min. Treatments were started
at different times so that they were all stopped at the same time.
Bovine Time Course
Bovine tissue fragments were incubated with serum free RPMI containing IL6 for differing amounts of time in 15 ml centrifuge tubes. The tubes with the tissue
were placed in a water bath and lightly shaken for the duration of the incubation at
5

37° C. Each sample contained ~200 mg of tissue. Times ranged from 0, containing
no IL-6, to 240 min. The treatment that did not receive any IL-6 during incubation
was incubated in serum free RPMI for the same amount of time as the longest
treatment. The treatments were started at different times so as to end at the same
time.
Dose Response experiments
Human Dose Response
Cultured H295R cells were incubated with DMEM/F12 serum free that
contained IL-6. Each plate of cells received a different concentration of IL-6, 0 – 100
pg/ml. The duration of incubation was 60 min. The cultured cells were placed in an
incubator set to 5% CO2 and 37° C. Treatments were started and stopped together.
Bovine Dose Response
Bovine tissue fragments were incubated in 5 ml of serum free RPMI
containing IL-6 in 15 ml centrifuge tubes. Each treatment received different
concentrations of IL-6. The tubes with the tissue were capped and placed in a water
bath at 37° C. They were lightly shaken for the duration of the incubation. Each time
treatment contained ~200 mg of tissue. Concentrations of IL-6 ranged from 0 – 100
pg/ml. The treatments were started and stopped at the same time, 60 min.
RNA extraction
RNA extractions for both H295R cells and bovine tissue were performed
using Trizol reagent and the protocol that comes with the Trizol (Sigma). For H295R
cells the incubation medium was removed from the plates and Trizol was added, 2 ml
per culture plate. Trizol reagent was allowed to sit on the plates for 2 min. The cells
were then scraped off the plate using a sterile cell scraper (Sarstedt). The liquid from
each plate was pipetted into a 15 ml centrifuge tube. The solution was incubated for
5 min to allow for complete lysis of the cells. Chloroform (0.5 ml chloroform per 1
ml of Trizol reagent) was then added to the solution. Upon addition of chloroform
the tubes were capped and were vigorously shaken for 15 sec after which they were
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placed in a Jouan centrifuge(company) and centrifuged at 3000 RPM for 20 min. The
centrifuge was refrigerated to 4° C. When the centrifugation was completed, the top
layer of the solution, the aqueous phase, was removed and put into a new 15 ml
centrifuge tube. Isopropyl alcohol was added (0.5 ml of isopropyl alcohol per 1 ml of
Trizol reagent) to this solution and incubated on ice for 10 min. After incubation the
solution was centrifuged again at 3000 RPM for 10 min. During this centrifugation,
an mRNA pellet formed at the bottom of the tube. The solution was removed and
75% ethanol was added (1ml 75% ethanol for every 1 ml of Trizol reagent) to wash
the pellet. After adding the ethanol the tubes were lightly shaken by hand to dislodge
the pellet from the bottom and allow for complete washing of the pellet. The 15 ml
centrifuge tubes were centrifuged again for 5 min. The solution was removed from
the tubes, and the pellet was allowed to dry for 5 – 10 min. Sterile nuclease free
water was then added to the pellet. Amount of water varied depending on the size of
the pellet. The 15 ml centrifuge tubes with the water and pellet were then placed in a
water bath at 60° C until the pellet was dissolved.
Bovine tissue that was used for RNA extractions was centrifuged for 5 min at
300 RPM. The tissue formed a pellet and the solution was removed. The tissue was
then removed from the centrifuge tube and placed into a homogenizer. 1 ml of Trizol
reagent was added and the tissue homogenized until it was no longer in large
fragments. This solution was poured into a new 15 ml centrifuge tube. The
homogenizer was washed with 1 ml of Trizol, and this was added to the solution in
the 15 ml centrifuge tube. This solution was incubated for 5 min to allow for
complete lysis of the tissue. Chloroform was added to the 15 ml centrifuge tubes and
the tubes were then centrifuged for 20 min at maximum RPM. After centrifuging the
solution was in three phases: Aqueous (top, clear), interphase (middle, white layer),
and organic (bottom, red). The aqueous phase was removed and placed into new 15
ml centrifuge tubes. Isopropyl alcohol was then added to the new 15 ml centrifuge
tubes, which contained the aqueous phase, to precipitate the RNA. This solution was
incubated on ice for 10 min and then centrifuged for 10 min. After centrifuging a
white pellet was found on the bottom of the tube. The supernatant was removed from
the tubes, and ethanol was added to wash the pellet. The tubes were then agitated to
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dislodge the pellet so it was completely washed. The tubes were then centrifuged for
5 min. The ethanol was removed after centrifuging, and the pellet was air dried for 5
– 10 min. Nuclease free water was added to the dry pellet, 50 – 300 µl depending on
the size of the pellet, and then the tube was placed in a water bath at 60° C until the
pellet dissolved.
RNA Quantification
NFW (150 µl) was added to a 0.2 ml microcentrifuge tube as a standard. NFW
(147µl) was added to all other tubes in which RNA would be quantified. 3 µl of
RNA solution was taken from each treatment group and added to the corresponding
0.2 ml tube with the 147 µl of NFW (for a total of volume150 ul). The tubes were
then vortexed and centrifuged. The solution was pipetted out of the 0.2 ml
microcentrifuge tubes and into a cuvette, one treatment at a time, and quantified using
a spectrometer (GeneQuant II Pharmacia Biotech, Cambridge, England). Once the
concentrations were known, calculations were made to find out how many µl of
sample were needed to obtain 2 µg of RNA for the RT (reverse transcriptase).
2 µg / concentration of sample * 1000 µl / 1 ml = µl of RNA sample to get 2 µg of
RNA
RT- Reverse Transcription
A large mixture of reagents was made that contained 2 µl 10x buffer, 1 µl dNTP
(deoxynucleotide triphosphates), 2 µl DTT, 0.4 ul random decamers, 1 µl RNase out,
and 1 µl superscript II, the reverse transcriptase. Each of these values was multiplied
by the number of treatments plus 1. From the grand mixture 7.4 µl was pipetted into
the appropriate number of 0.2 ml microcentrifuge tubes, one for each treatment. 2 ug
of RNA was added to the 0.2 µl tubes (the volume of sample to obtain 2 ug of RNA
was calculated during the quantification). Nuclease free water was added to bring the
total volume to 20 µl. The tubes were then centrifuged, vortexed, and placed in a
thermocycler (Gene Amp PCR system 2400 Perkin Elmer, Waltham, Massachusetts).
The program was set to run for 60 min at 42° C.
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Standard PCR- Polymerase chain reaction
A grand mixture was also made of the PCR reagents. The grand mixture was
39.975 µl of NFW, 5 µl of 10x buffer, 0.625 µl of 0.4 mM nucleotide triphosphate
mixture (dNTP), 2 µl of 0.1 nmole/µl mixture of sense and anti-sense of the primer
which would be used, and 0.4 µl of Jstaq (250 units of DNA polymerase). These
volumes were multiplied by the number of treatments plus 1. A different grand
mixture was made for each primer used. 48 µl aliquots of the grand mixture were
pipetted into 0.2 µl microcentrifuge tubes. 2 µl of the RT was then added making the
total for each 0.2 ml tube 50 µl. The tubes were then vortexed, centrifuged, and
placed in the thermocycler (Gene Amp PCR system 2400 Perkin Elmer, Waltham,
Massachusetts). The thermocycler was programmed to cycle 35 – 55 times. The
initial step denatured the cDNA. The temperature and time for this step was 95° C
and 3 min. The next three temperatures were the temperatures that cycle 35 – 55
times. The first temperature of the cycle denatured the template and newly made
complementary strand. This step required 95° C and different durations of time
ranging from 20 sec to 30 sec depending on the length of the amplified sequence.
The second temperature allowed for the annealing of the primer to the target cDNA.
This step was set to different temperatures ranging from 55° – 58° C depending on
the length of the primer and percent of purines and pyrimidines. The duration of this
step ranged from 20 to 30sec. The third temperature was 72° C. This temperature
was optimal for polymerase function and elongation of the amplified sequence. The
duration of this step was changed depending on the length of the amplified sequence
and ranged from 20 sec to 1 min. The final two temperatures of the thermocycler
program were 72° C for 3 min for final elongation and 4° C for stopping
inappropriate reactions until the PCR mixture was frozen (diagram 2).
Electrophoresis
The agarose gel was made by mixing 50 ml of 1x Tris-Acetate/EDTA
electrophoresis buffer (1x TAE) with 0.5 g of agarose in a beaker and covered with
plastic wrap. The solution was microwaved for 1 min. Then 2.5 µl of ethidium
bromide was added to the solution. Once it was mixed, the solution was poured into
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the gel tray and all bubbles were removed, the comb was then added to create the
wells. The solution was then allowed to harden for 25 min.
10 µl of the PCR solution was mixed with 2 µl of loading dye and placed in a
well of the gel. Also, 3 µl of DNA ladder was placed into a well. The
electrophoresis machine was set to 80 V and allowed to run for 25 min.
After 25 min the gel was removed from the tray and a picture was taken by
reflecting ultraviolet light off of the gel. This was done using a computer camera
(Alpha Innotech Corporation, Fluorchem 8900). The quantification was also done on
the computer (Fluorchem 8900 software).
Real-Time PCR
(The converting of RNA to cDNA was done in the same manner as for
standard PCR but was diluted with sterile nuclease free water by a factor of 50 for use
in real time PCR).
Grand mixtures were made using a PCR supermix (2x mix contains 100 mM
KCl, 40 mM Tris-HCl, pH 8.4, 0.4 mM each dNTP (dATP, dCTP, dGTP, dTTP), 50
U/ml iTaq DNA polymerase, 6 mM MgCl2- iQ Sybergreen Supermix). The volume
of supermix was 6.25 µl times the number of reactions, plus 20% (# of reactions
equals # treatments times the # of replicates). Primers (0.5 µl times the # of
replicates, plus 20%) and sterile nuclease free water (4.75 µl times the # of replicates,
plus 20%) were added to the PCR supermix in a 1.5 ml centrifuge tube. One 1.5 ml
tube was prepared for each different primer. The 1.5 ml tubes were then vortexed
and centrifuged. The mixture was then pipetted into 0.2 ml centrifuge tubes (total
volume of grand mixture divided by the number of treatments), one 0.2 ml tube for
each treatment. The RNA template was added to the 0.2 ml tubes at this point (0.167
µl times the number of reactions, times 1.4). Each 0.2 ml tube was vortexed and
centrifuged. The contents of the 0.2 ml tubes were pipetted into corresponding wells
of a 96-well plate (12.5 µl per well). The 96-well plate was then covered with sealing
film and placed in the thermocycler (MyiQ Bio-Rad Laboratories, Hercules,
California).
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The thermocycler monitored and recorded the light emitted from the sample.
The emitted light is produced from ultraviolet light when shone on SYBR green
while the SYBR green reacts with the phosphate groups of DNA.
Melting temperatures of the products (fig.33) and gel electrophoresis of the
products (pictures not shown) were used to identify the product and determine that
only one product was being amplified by each primer used in real time PCR
reactions.
Primer Design
Primers were designed using a primer design computer program from
Invitrogen, Vector NTI, and ABI, Primer Express. The parameters were set to
produce primers that would work with real-time PCR as well as standard PCR.
Primers were made for DAX-1, SF-1, StAR, P450scc, 17α hydroxylase, 3β
hydroxysteroid dehydrogenase type 2, 21 hydroxylase, and 11β hydroxylase. Human
and bovine specific primers were made.
Western Blotting
Protein extraction, H295R cells
After the completion of the treatment interval, the cells were rinsed in 1X PBS
at room temperature. The 100 mm culture plates were then placed on ice and 0.6 ml
of Radioimmunoprecipitation (RIPA) buffer was added. (100 ml of RIPA buffer
contains 1 ml Nonidet P-40, 0.5 g Sodium Deoxycholate, 0.1 g SDS, and 1X PBS to
bring the total volume to 100ml. At the time of use 10 µl/ml of a 10 mg/ml
concentration of Phenylmethyl sulfonyl fluoride, 30 µl/ml of aprotinin (Sigma), and
10 µl/ml of 100 mM sodium orthovanadate were added to the stock RIPA buffer).
The culture plates were gently rocked for 15 min using a rocking platform from VWR
Scientific Products (model 100). The culture plates were then scraped using a sterile
cell scraper and the contents were pipetted into a 1.5 ml microcentrifuge tube. The
solutions were then incubated on ice for 60 min. The tubes were then centrifuged at
10,000 G for 10 min at 4° C. The supernatant was transferred to another 1.5 ml
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microcentrifuge tube and pellet discarded. Total concentration of protein was
quantified using the Bradford assay.
Protein extraction, Bovine tissue
The bovine tissue, after treatment was complete, was centrifuged for 5 min at
300 RPM. The supernatant was discarded and the tissue was scraped into a
homogenizer. 800 µl of lysing buffer was added into the homogenizer (4 ml per gram
of tissue, 200 mg of bovine tissue), and the tissue was homogenized until no large
fragments remained. (Stock lysing buffer consisted of 0.79 g Tris-HCl, 4.6 g
Mannitol, 0.21 g NaF 0.22 g Sodium pyrophosphate, 0.037g EDTA, 0.038 g EGTA,
1 ml Triton X100, 10 ml of glycerol, and distilled water to bring the total volume to
100 ml. At time of use 50 µl of a 1 mM concentration of PMSF, 0.0154 g of
dithiothreitol (Cleland’s reagent, or DTT) (GIBCO), 0.0156 g of Benzamidine, and
0.1 mg of soybean Trypsin inhibitor (SIGMA) were added to the 100 ml stock
solution).The solution was poured into a 1.5 ml microcentrifuge tube and incubated
on ice for 60 min. The tubes were then centrifuged for 10 min at 10000 G. The
solution was then frozen and stored in a freezer at -90° Celsius. Total concentration
of protein was determined using the Bradford assay.

Electrophoresis
10 µl of sample was loaded into a well of a polyacrylamide gel, one treatment
per well, with a protein ladder also in a well alone. The gels (10%, BioRad) were
electrophoresed for ~30 min at 200 V in a mini protean II (BioRad). The gels were
removed; wells were cut away from the body of the gel, and placed in transfer buffer
for 20 min with gentle rocking. After soaking the gels for 20 min they were placed in
transfer cassettes. Transfer cassettes were assembled in a transfer cell (mini transblot
cell, BioRad) and filled with transfer buffer. Proteins were transferred for 60 min at
100 mV. The amperes were adjusted to be above 200 mAMPs. Once transfer was
complete the nitrocellulose membrane (BioRad) was soaked in a 5% milk/PBST
solution with gentle rocking for 1 hour to cover the membrane with a non-specific
protein. After blocking nonspecific binding with milk the membrane was washed for
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30 min. Washing started with PBST which was removed after 10 min and fresh
PBST was put on. The second PBST solution was removed and PBS administered
20min into the wash. A final wash of PBS was applied 25 min after starting the
washing process. At this point the primary antibody solution, 2% milk/PBST, was
administered. The membrane was left, with the antibody solution, in a refrigerator
overnight. The next day the antibody solution was poured off, and the membrane was
washed with PBST and PBS for 30 min, PBST twice for 10 min and PBS twice for 5
min. The secondary antibody solution, 2% milk/PBST, was placed on the membrane
for 1 hour. The antibody solution was removed from the membrane, and the
membrane was washed with PBST and PBS for 30 min after. The washing consisted
of PBST twice for 10 min each and PBS twice for 5 min each. At this point a picture
was taken of the membrane. This was done by applying a detection solution (western
blotting luminol reagent, Santa Cruz Biotechnology, Inc.) while in the darkroom, and
placing a sheet of photo paper over the membranes to detect light emitted. The photo
paper was processed in a developing machine and a computer was utilized to quantify
the density of the bands (Fluorchem 8900, Alpha Innotech).
Antibodies
Antibodies for DAX-1, SF-1, StAR, P450scc, 17α hydroxylase, 3β
hydroxysteroid dehydrogenase type 2, 21 hydroxylase, and 11β hydroxylase were
obtained from Santa Cruz. These antibodies were anti-human but were used for, and
bound, the bovine proteins.
Results
Steroidogenic Factor-1/DAX-1
In the first series of experiments, the effects of IL-6 on the expression of the
nuclear factors, Steroidogenic factor-1 (SF-1) and dosage sensitive sex reversal
adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX-1)
were determined. SF-1 causes activation of transcription for the steroidogenic genes
whereas DAX-1 causes repression of these genes (22). To determine the effects of
IL-6 on the mRNA and protein levels for the two transcription factors human H295R
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cells and bovine ZF and ZR tissue were exposed to IL-6 in a time-dependent or dosedependent manner. RT-PCR and western blot were utilized to quantify a change in
the mRNA or protein.
Human H295R
In the human adrenocortical cell line H295R IL-6, in a time-dependent
manner, decreased DAX-1 mRNA. A statistically significant decrease was first
observed at 30 min which continued through 100 min (Fig. 1C). Similarly, IL-6
decreased significantly DAX-1 protein starting at 30 min and continuing through
120min of incubation (Fig. 2). In experiments utilizing different concentrations of
IL-6, IL-6 decreased DAX-1 mRNA in a concentration-independent manner within
the 60 min incubation interval. The decrease in DAX-1 mRNA was statistically
significant with 1, 10, and 100 pg/ml IL-6 (Fig. 1A).
In contrast to DAX-1, IL-6 increased the expression of the mRNA and protein
for SF-1. SF-1 mRNA increased significantly, 2.5 fold, at 100 min of incubation
(Fig. 1C). Similarly, SF-1 protein level peaked at 120 min,1.5 fold (Fig. 2A). SF-1
protein was significantly increased from 30 – 120 min of incubation. The
concentration-related effects of IL-6 on SF-1 expression demonstrated an increasing
pattern in which SF-1 increased significantly with 10 and 100 pg/ml IL-6, 1.8 and 1.5
fold respectively (fig. 1A).
To better clarify the relationship between DAX-1 and SF-1, the SF-1 to DAX1 ratio was calculated. In the time course experiments, IL-6 exposure resulted in a
significant increase in the ratio of SF-1:DAX-1 mRNA after 100 min of exposure to
IL-6, 5 fold increase (Fig. 1D). The protein ratio increased significantly by 10 min
and continued to increase to 30 min. Between 60 and 120 min the ratio dropped to a
significant, 4 fold, increase (Fig. 2B). The ratio was statistically increased at all time
intervals, 30, 60, and 120 min..
Bovine Zona Fasciculata
Similar to the H295R cells, IL-6 increased SF-1 protein and decreased DAX-1
protein in bovine ZF tissue. IL-6 decreased DAX-1 in a time-dependent manner with
a decrease of 60% in DAX-1 protein at 120 min (Fig. 3A). The ZF tissue was very
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sensitive to the IL-6-induced decrease in DAX-1. IL-6 concentrations of 1 pg/ml
caused maximal inhibition of DAX-1 protein (Fig. 4A). More data is needed to
determine if the change in protein is significant.
SF-1 protein increased in a time-dependent manner in bovine ZF tissue
increasing within 30 min and reaching a 2.5 fold increase at 70 min (Fig. 3A). Dosedependent treatments increased SF-1 protein an average of 2.5 fold with all three
concentrations (Fig. 3A). More data is needed to determine if the change in protein is
significant.
The protein ratio of SF-1:DAX-1 of ZF tissue treated in a time-dependent
manner increased 5 fold at 120 min (Fig. 4B). The ratio of SF-1:DAX-1 protein in
dose-dependent treatments increased with all concentrations with maximal effect
being reached with 10 pg/ml (Fig. 4B). More data is needed to determine if the
change in protein is significant.
Bovine Zona Reticularis
Because IL-6 inhibits the release of adrenal androgens from the bovine
adrenal ZR, the effects of IL-6 on DAX-1 and SF-1 in ZR fragments were examined.
To determine if the effect of IL-6 was time dependent, bovine ZR tissue was exposed
to IL-6 (50 pg/ml) for time intervals from 10 – 120 min. IL-6 increased DAX-1
protein with a bi-nodal effect peaking at 30 min with a 2.5 fold increase which was
down to a 1.5 fold increase at 70 min. By 120 min the protein was back up to a 2.25
fold increase (Fig. 5A). SF-1 protein decreased in a time dependent manner. SF-1
protein decreased 40% by 120 min (Fig. 5A). The ratio of SF-1:DAX-1 protein
levels decreased 60% by 120 min (Fig. 5B). More data is needed to determine if the
change in SF-1:DAX-1 protein is significant.
To determine if the effects of IL-6 on SF-1 and DAX-1 in ZR tissue were
dose dependent, ZR fragments were incubated with different concentrations of IL-6
for 60 min. DAX-1 protein increased with 1 and 10 pg/ml IL-6, 20% (Fig. 6A). SF-1
protein decreased with all concentrations of IL-6 with 10 and 100 pg/ml causing the
largest effect (Fig. 6A). The ratio of SF-1:DAX-1 protein showed a decrease of 40%
with both 1 pg/ml and 10 pg/ml (Fig. 6B). More data is needed to determine if the
change in protein is significant.
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StAR
Because IL-6 affected the expression of DAX-1 and SF-1, nuclear factors that
regulate steroidogenesis, increase cortisol release from the ZF and decrease adrenal
androgen release from the ZR, the effects of IL-6 on the expression of StAR were
determined. StAR transports cholesterol across the outer mitochondrial membrane
where it can start the conversion to a steroid. This step is the rate limiting step of
steroidogenesis.
Human H295R
In H295R cells, standard PCR demonstrated a significant, 2.5 fold, increase in
StAR mRNA after 10 min exposure to IL-6 (Fig. 7). Likewise, StAR protein
significantly increased 2 fold with 10 min of IL-6 exposure, at 30 min the increase
was no longer significant. By 60 min StAR protein was significantly increased again
and remained significantly increased through 120min (Fig. 8). To determine if the
effect of IL-6 on StAR mRNA and protein was concentration dependent, H295R cells
were incubated in medium containing different concentrations of IL-6 for 60 min.
IL-6, 10 pg/ml, increased significantly, 2 fold, StAR mRNA levels. StAR mRNA was
also significantly increased with 100 pg/ml (Fig 9).
Bovine Zona Fasciculata
Similar to H295R cells, IL-6 increased StAR mRNA and protein expression in
ZF tissue in a time-dependent and concentration-independent manner. Real time
PCR showed a significant change in mRNA at 30 min and 240 min of incubation, 2
fold at both time points (Fig. 10). The protein levels showed a 40% increase at 30
min which slowly decreased to 20% at 90 min (Fig. 16), more data is needed to
determine if the change in protein is significant. Differing doses of IL-6 showed a
significant 4 fold increase in mRNA with as little as 1 pg/ml, 10 pg/ml did not
significantly increase in StAR (Fig. 11). Protein levels increased with 10 and 100
pg/ml causing a 1.5 and 2 fold increase respectively (Fig. 12), more data is needed to
determine if the change in protein is significant.
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Bovine Zona Reticularis
Bovine ZR cells treated with 50 pg/ml of IL-6 demonstrated a significant
decrease in StAR mRNA levels of 60% within 30 min of incubation time and further
decreased to 20% of the level of non-treated cells at 120 min (Fig. 13). StAR protein
decreased 40% at 240 min, more data is needed to determine if the change is
significant (Fig. 17). Bovine ZR tissue exposed to differing concentrations of IL-6
demonstrated a significant 30% decrease in mRNA levels with 10pg/ml IL-6 and
maximal effect was reached with 100 pg/ml, 40% decrease (Fig. 14). StAR protein
decreased significantly, and maximally, with 100 pg/ml IL-6, 45% (Fig. 15).
P450scc
P450scc is the first enzyme involved in the conversion of cholesterol to
adrenal steroids. P450scc is found in the mitochondria and is the next rate limiting
step, after translocation of cholesterol into the mitochondria by StAR. Transcription
of P450scc has been demonstrated to be regulated by SF-1 and DAX-1. Therefore,
the effects of IL-6 on P450scc protein and mRNA were determined using RT-PCR
and western blot.
Human H295R
In H295R cells standard PCR demonstrated an increasing trend from 0 – 100
min. P450scc mRNA increased significantly at 60 min and was found to be not
significantly elevated at 100 min (Fig. 7). Likewise, the protein levels for P450scc in
H295R cells increased significantly within 10 min, and remained elevated, 2.2 fold,
out to 120 min (Fig. 8).
To determine if the effects of IL-6 were dose dependent H295R cells were
incubated in differing concentrations of IL-6 for 60 min. Standard PCR showed a
significant increase in mRNA levels starting with 1 pg/ml of IL-6 (Fig. 9). Maximal
effect was reached with 1 pg/ml, but 10 and 100 pg/ml also increased p450scc mRNA
significantly.
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Bovine Zona Fasciculata
Similar to H295R cells, IL-6 increased P450scc mRNA and protein in bovine
ZF tissue. Real time PCR demonstrated a 4 fold increase at 140 min (Fig. 10).
P450scc mRNA was significantly increased between 80 and 140 min, by 240 min the
increase was no longer significant. Protein levels of P450scc detected by western
blot showed an increase of 30% within 70 min and remained elevated, 20%, beyond
120 min (Fig. 18). More data is needed to determine if this effect on P450scc protein
was significant.
The dose-dependent treatments of IL-6 elucidated the effect of IL-6 on
P450scc mRNA and protein in bovine ZF fragments was not concentration
dependent. Real time PCR demonstrated a larger effect with 1 pg/ml than the 10
pg/ml (Fig. 11). Both 1 and 10 pg/ml IL-6 exposure increased P450scc mRNA
significantly, 2.4 and 2 fold respectively. Protein levels of P450scc in ZF fragments
treated with differing concentrations of IL-6, likewise, showed an increasing trend
with maximal effect being reached with 1 pg/ml of IL-6 (Fig. 12). More data is
needed to determine if the effect on P450scc protein is significant.
Bovine Zona Reticularis
Because IL-6 decreased the SF-1:DAX-1 ratio in bovine ZR fragments, and
the SF-1:DAX-1 ratio is thought to be a major factor of steroidogenesis by
influencing the expression of steroidogenic enzymes, the effect of IL-6 on P450scc
mRNA and protein was examined. To determine the effect of IL-6 on P450scc
mRNA and protein in the bovine ZR, bovine adrenals were dissected, the ZR
insolated, cut into fragments, and treated with IL-6. Real time PCR showed a
significant decrease, 40%, in P450scc mRNA within 30 min of incubation (Fig. 13).
At 240 min the mRNA level had plunged significantly to 20% of the control level.
Western blot analysis demonstrated a similar trend (Fig. 21). Within 30 min of
incubation the protein level for P450scc had dropped 80% and remained at this level
beyond 240 min. More data is needed to determine if the change in protein is
significant.
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Because IL-6 was determined to have a time-dependent effect, it was also
necessary to elucidate the concentration-dependent effect of IL-6 on P450scc mRNA
and protein in the bovine ZR. Real time PCR on cellular extracts from bovine ZR
fragments demonstrated a dose response curve starting with 10 pg/ml of IL-6 and
continuing to 100 pg/ml of IL-6 (Fig. 14). A significant 50% decrease was observed
with 1 pg/ml and a 70% decrease with 100 pg/ml. Protein level detected by western
blot demonstrated a significant decrease with 1, 10, and 100 pg/ml, 24%, 20%, and
21% respectively (Fig. 15).
17α Hydroxylase
17α hydroxyl is a unique enzyme because it is known to have two definitive
catalytic functions. It converts pregnenalone to 17 hydroxy-pregnenalone and 17
hydroxy-pregnenalone to DHEA. The conversion of 17 hydroxy-pregnenalone to
DHEA is augmented by cytochrome b5 in the ZR. Therefore, DHEA is largely
produced in the ZR.
Human H295R
In the human H295R cell line, standard PCR was used to quantify changes in
mRNA for 17α hydroxylase. Data demonstrated a significant increase in 17α
hydroxylase mRNA after 100 min of IL-6 exposure. An average increase of 3.5 was
observed at 100 min (Fig. 7). Protein levels increased significantly at 30 min,
reached 2 fold at 50 min, and remained significantly increased beyond 120 min (Fig.
8).
Bovine Zona Fasciculata
Similar to H295R cells, bovine ZF fragments increased 17α hydroxylase
mRNA and protein in response to IL-6 exposure. Real time PCR demonstrated a
significant increase in 17α hydroxylase mRNA starting at 30 min of incubation (Fig.
10). 17α hydroxylase mRNA remained significantly elevated through 240 min.
Protein levels increased 50% with 10 min of exposure to IL-6. 17α hydroxylase
protein demonstrated an increasing trend through 240 min (Fig. 20). More data is
needed to determine if the change in protein was significant.
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Because IL-6 increased 17α hydroxylase mRNA and protein in a timedependent manner, experiments were performed to clarify whether the mechanism
was dose-dependent. Real time PCR determined the mechanism of IL-6 to be
concentration independent. 1 and 10 pg/ml IL-6 significantly increased 17α
hydroxylase mRNA. Maximal effect was reached with 1 pg/ml (Fig. 11). Likewise,
protein levels did not demonstrate a dose-dependent mechanism with 100 pg/ml IL-6
causing the same response as 1 and 10 pg/ml (Fig. 12). More data is needed to
determine if the change in protein is significant.
Bovine Zona Reticularis
Because 17α hydroxylase is necessary for adrenal androgen production, the
effect of IL-6 on 17α hydroxylase mRNA and protein was determined. Bovine ZR
tissue treated with IL-6 for 120 min demonstrated an 80% decrease in 17α
hydroxylase mRNA. A significant decrease was seen starting at 30 min of
incubation, 40% and continued through 120 min (Fig. 13). Protein levels decreased
80% within the first 10 min of exposure to IL-6 and remained decreased for 240 min
(Fig. 21). More data is needed to determine if the change in protein is significant.
The next necessary step was to elucidate the concentration-dependent effects
of IL-6 on the ZR. ZR tissue treated with different concentrations of IL-6
demonstrated a mechanism that was concentration independent within 60 min.
Treatments of 5 – 100 pg/ml significantly decreased 17α hydroxylase mRNA levels
25% and 40% respectively (Fig. 14). Protein levels decreased significantly, 30% –
45%, with exposure to IL-6 (Fig. 15). Maximal effect was reached with 100 pg/ml.
3-β Hydroxysteroid Dehydrogenase type 2
3β hydroxysteroid dehydrogenase type 2 (3β HSD2) is not a cytochrome
containing enzyme like the other enzymes in this steroidogenic pathway. It removes
a hydrogen atom from the hydroxyl group on the number 3 carbon of
cyclopentanophenanthrene body converting it to a ketone. In this process the double
bond between carbons 5 and 6 is hydrogenated and a new double bond is formed
between carbons 4 and 5. Because 3β HSD2 is known to be regulated by SF-1 and
DAX-1 and is essential for cortisol and androgen production, H295R cells and bovine
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tissue fragments were exposed to IL-6 to determine the effect on 3β HSD2 mRNA
and protein.
Human H295R
In the human cell line H295R, IL-6 increased 3β HSD2 mRNA in a timedependent manner. Standard PCR demonstrated a significant 100% increase in
mRNA at 60 min which remained significantly elevated through 100 min (Fig. 7).
IL-6 was determined to act independently of concentration within 60 min on
3β HSD2 mRNA and dependent on concentration for protein. 1 pg/ml IL-6
significantly increased 3β HSD2 mRNA 3.5 fold, and 100 pg/ml 3 fold (Fig. 9).
Maximal effect was reached with 1 pg/ml, and significant increases were observed
with 1, 10, and 100 pg/ml.
Bovine Zona Fasciculata
Similar to H295R cells, bovine ZF treated with IL-6 demonstrated a timedependent mechanism on 3β HSD2 mRNA and protein. 50 pg/ml IL-6 increased 3β
HSD2 mRNA significantly at 30 and 80 min, quantified using real time RT-PCR
(Fig. 9). At 240 the increase was 2 fold but was not significant. Protein levels,
measured by western blot, peaked at a 0.6 fold increase at 90 min (Fig. 22). At 240
min the increase in 3β HSD2 protein was 20%. More data is needed to determine if
the change in protein was significant.
Experiments were performed to determine if the mechanism of IL-6 on 3β
HSD2 was concentration dependent. Bovine ZF tissue treated in a dose dependent
manner showed the mechanism of IL-6 on 3β HSD2 mRNA was concentration
dependent. Real time PCR demonstrated a 3.5 fold increase of 3β HSD2 mRNA with
1 pg/ml and a 4 fold increase with 10 pg/ml (Fig. 11). 3β HSD2 protein increased
20% with 1 pg/ml (Fig. 12). Maximal effect was reached with 1 pg/ml. More data is
needed to determine if the change in protein was significant.
Bovine Zona Reticularis
3β HSD2 is more abundantly expressed in the ZF than the ZR (18). However,
3β HSD2 is necessary for conversion of DHEA to other adrenal androgens. Bovine
ZR tissue treated with 50 pg/ml of IL-6 for 120 min showed a significant 90%
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decrease in 3β HSD2 mRNA. 10 min exposure decreased significantly 3β HSD2
mRNA 40%, all time points in between were significantly decreased (Fig. 13).
Different concentrations of IL-6 elucidated a significant 25% decrease with 1
pg/ml in 3β HSD2 mRNA. Concentrations of 10 and 100 pg/ml caused a greater
effect than 1 pg/ml, and only 10 and 100 pg/ml IL-6 caused a significant decrease
compared to controls (Fig. 14). 3β HSD 2 protein also decreased significantly with 1,
10, 100 pg/ml, 30%, 40%, and 50% respectively (Fig. 15).
21 Hydroxylase
21 hydroxylase is found in all zones of the adrenal cortex, ZG, ZF, and ZR
(18). Located in the endoplasmic reticulum 21 hydroxylase oxidizes the 21 carbon of
the cyclopentanophenanthrene steroid body by addition of a hydroxyl group.
Because several of the enzymes involved in steroidogenesis are regulated by the SF1:DAX-1 ratio the effect on 21 hydroxylase was examined.
Human H295R
Standard RT-PCR showed a significant increase in 21 hydroxylase mRNA
starting after 100 min of exposure to IL-6, 3 fold (Fig. 7). 21 hydroxylase protein
showed an increasing trend, however, it was not found to be significant at any time
point (Fig. 8). .
Bovine Zona Fasciculata
Similar to H295R cells, bovine ZF tissue increased 21 hydroxylase mRNA in
response to IL-6. Real time PCR demonstrated a time-dependent effect of IL-6 on
bovine ZF tissue. 21 hydroxylase mRNA increased significantly at 30 min, 3 fold
(Fig. 10). The mRNA level peaked with a significant increase of 3.5 fold at 80 min
and fell to a 2 fold increase at 240 min. After 80 min of incubation 21 hydroxylase
mRNA was not significantly increased. Because IL-6 affected 21 hydroxylase in a
time-dependent manner, experiments were performed to determine if the mechanism
of IL-6 was dose-dependent. 1 pg/ml of IL-6 significantly increased, maximally, 3
fold 21 hydroxylase mRNA. The 10 pg/ml significantly increased 21 hydroxylase
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mRNA 2 fold (Fig. 11). Therefore, IL-6 did not show a dose dependent mechanism
at the mRNA level.
11β Hydroxylase
11β hydroxylase type 1 is found specifically in the ZF and ZR of the adrenal
cortex (18). It is the last step in the production of cortisol and is found in the
mitochondria. The first and last steps in the production of cortisol are performed in
the intra-membrane space of the mitochondria. Experiments were performed to
elucidate the mechanism of IL-6 on human cells and bovine ZF tissue on 11β
hydroxylase.
Human H295R
11β hydroxylase mRNA increased significantly at 60 min and remained
significantly elevated through 100 min, 3 and 2 fold respectively (Fig. 7). Likewise,
11β hydroxylase protein increased significantly 3.2 fold after 60 min of exposure to
IL-6. Protein levels remained significantly elevated through the 120 min incubation
period (Fig. 8).
Bovine Zona Fasciculata
Analogous to H295R cells, bovine ZF increased 11β hydroxylase in a timedependent manner when exposed to IL-6. Real time PCR demonstrated a significant
increase in 11β hydroxylase mRNA of 4 fold at 30 min and remained significantly
increased through 80 min. At 140 min a 2 fold increase was observed which
increased to 3 fold between 140 – 240 min (Fig. 10). Only the 30 and 80 min time
points were significantly increased compared to controls.
Concentration-dependent exposures to IL-6 demonstrated a concentration
independent mechanism at the protein and mRNA level. Real time PCR
demonstrated an increasing trend but no treatment was found to be significantly
increased (Fig. 11). Likewise, 11β hydroxylase protein demonstrated an increasing
trend, but more data is needed to determine if the effect is significant (Fig. 12).
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Discussion
Human and Bovine Zona Fasciculata
IL-6 is a cytokine released from numerous tissues including the immune
system, exercising muscle, damaged tissue, and the adrenal cortex. IL-6 increases
cortisol release from the human and bovine adrenal. The biochemical effects through
which IL-6 increases cortisol production have not been identified. IL-6 binds to the
IL-6 receptor which dimerizes and activates JAK proteins. JAK proteins then
phosphorylate STAT proteins, which are nuclear factors that increase transcription of
specific genes. Likewise, JAK proteins are capable of phosphorylating and activating
other pathways which lead to increased transcription. Two of these looked at in this
study were SF-1 and a transcription inhibitor DAX-1. It was found that the ratio of
these to transcription factors was more important than the level of each by itself.
Individual cells could have different basal expression of these factors. Therefore, the
ratio of the two would be more important in determining the steroidogenic state of the
cells/tissue. IL-6 has not previously been shown to decrease DAX-1. DAX-1 has
been shown to be down regulated by ACTH in a mouse tumor cell which has the ZF
phenotype (22). IL-6 uses a different receptor than ACTH and initially different
cellular molecules. In both human and bovine ZF, DAX-1 protein and mRNA
decreased rapidly, within the first 60 min. This decrease can not all be explained by
reduced transcription and translation rate alone. Therefore, IL-6 could be activating a
pathway which leads to the degradation of the DAX-1 protein. Likewise, SF-1
protein increases rapidly. The increase in SF-1 protein can not exclusively be
explained by an increase in translation. IL-6 could be causing the inhibition of the
degradation of SF-1 protein. Although an increase in SF-1 has be correlated with an
increase in steroidogenesis, the change in the SF-1:DAX-1 ratio is not driving the
increase in steroidogenesis. IL-6 has been shown to increase AP-1 proteins and the
phosphorylation of these proteins (35). Also, STAT proteins have been shown to
bind to the StAR promoter and increase StAR promoter gene activity (36).
Therefore, the SF-1:DAX-1 ratio could be involved in fine adjustments of the level of
steroidogenesis. The increase in SF-1:DAX-1 ratio does correlate with an increase in
StAR, P450scc, 17α hydroxylase, 3β HSD2, 21 hydroxylase, and 11β hydroxylase at
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the mRNA level. Therefore, SF-1 and other transcription factors could be forming a
complex on the DNA at a promoter region. The promoter might be more active when
the whole complex is present but still be active, to a lesser extent, with just a few
components, ie. STAT, SF-1, CREB, and AP-1 proteins.
StAR mediates the rate limiting step of steroidogenesis. Therefore, a slight
rise in StAR protein levels would cause a large increase in steroid production. In this
study StAR protein levels increased but only 20 to 60 percent. This change was very
small compared to changes in some of the enzymes. Likewise, the change in StAR
protein was found to be bi-phasic, rising significantly at 10 min of incubation and
being non-significant at 30 min. By 60 min StAR protein was significantly increased
again. This rapid increase could cause rapid rise in cortisol in response to an acute
stimuli. This effect seems to be regulated at the protein level only suggesting a
change in the rate of inactivation/degradation of StAR.
StAR mRNA increased within 10 min in the human and 30 min in bovine ZF
tissue and remained at this point for the remainder of incubation time. miRNA which
was predicted to regulate StAR mRNA has been shown to increase in H295R cells
when incubated in cAMP containing medium (37). This suggests the mRNA for
StAR is closely regulated to allow for quick decrease in steroidogenesis when the
stimulation is stopped.
SF-1 is required for the expression of most steroidogenic enzymes. In
contrast, DAX-1 inhibits the expression of steroidogenic enzymes and StAR.
Therefore, an increase in the SF-1:DAX-1 ratio could in part be driving the increase
in expression of the steroidogenic enzymes and StAR in human and showing an
increasing trend in the bovine ZF tissue.
Protein levels for the enzymes increased rapidly in the H295R experiments
and the bovine model seems react in the same manner. This increase was too fast for
do novo synthesis. Therefore, it is likely that IL-6 affects the protein level of these
enzymes by decreasing the rate of degradation.
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Bovine Zona Reticularis
The effect of IL-6 on the ZR is not well understood, but in previous studies
IL-6 has been shown to decrease DHEA production in bovine ZR tissue (20).
Because the human cell line used in this experiment is a tumor cell line, it was not
possible to determine the effects of IL-6 on human adrenal zona reticularis cells.
Therefore, only bovine ZR adrenal tissue was used. The ZR fragments were
dissected out and incubated with IL-6 containing RPMI.
It was found that IL-6 has an opposite effect in the bovine ZR than it has in
the bovine ZF. IL-6 decreased the mRNA and preliminary results show a decreasing
trend in protein for: StAR, SF-1, P450scc, 17α hydroxylase, and 3β HSD2. It also
increased the mRNA and protein for DAX-1. Therefore, the SF-1:DAX-1 ratio in the
ZR decreased which would cause a decrease in steroidogenesis.
The effect in the ZR is opposite of the effect in the ZF when stimulated with
IL-6. This could be influenced by the suppressor of cytokine signaling (SOCS)
proteins and other SOCS-box (a sequence of amino acids that interacts with ubiquitin
ligase) containing proteins which are activated by cytokines. IL-6 has been shown to
increase activation of SOCS-1 (32). Different levels of methylation of SOCS-1 gene
were shown to cause different effects. High levels of methylation would cause the
gene silencing and therefore high activation of STAT in response to IL-6. When the
gene was void of methylation STAT activation was decreased in response to IL-6.
Therefore, the SOCS-1 gene could be regulation differently in the ZF and ZR tissues.
Moreover, the decrease in protein levels of the steroidogenic enzymes and
StAR could be influenced by the increase in SOCS protein activation. The SOCS
proteins have been shown to increase the ubiquitination of cytokine receptors (33, 34)
and the increase in SOCS-box containing proteins maybe regulating the enzyme
levels and StAR in the ZR tissue.
Likewise, StAR protein and mRNA were decreased with IL-6 treatment in the
bovine ZR. This effect was seen to be time-dependent but not dose-dependent for the
60 min of incubation. StAR is the rate limiting step of steroidogenesis. Therefore, a
decrease in StAR would decrease the ability to produce steroids.
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Similar to the human cell line and bovine ZF, the effect of IL-6 on the bovine
ZR might be partly be controlled by the SF-1:DAX-1 ratio. DAX-1 is a transcription
inhibitor which binds DNA and does not allow for the transcription to occur.
Therefore, the increase in DAX-1 would decrease the transcription of the
steroidogenic enzymes and StAR shift the state of the tissue away from
steroidogenesis. The decrease in steroid production would cause a decrease in DHEA
and other adrenal androgens produced by the adrenal ZR.
Protein levels of the enzymes, transcription factors, and StAR changed
rapidly. This change in protein decreased as fast as the mRNA in many experiments.
This decrease is hypothesized to be related to protein breakdown and not just a
decrease in mRNA and translation. Therefore, IL-6 might decrease production of
adrenal androgens by increasing processing of StAR and the steroidogenic enzymes
in the bovine ZR.
Future Experiments
Continue with the western blots for the ZF and ZR tissue and H295R dose
dependent treatments. More data is needed to determine if the preliminary results are
valid.
To determine if SOCS proteins might be involved western blots will be done
to find out basal and IL-6 stimulated levels in bovine ZF and ZR tissue. If the levels
are significantly different between the two tissues then the amino acid sequence of
the enzymes will be searched to find sequences that might interact with the SOCSbox and increase ubiquintination of the enzymes.
There have been many transcription factors shown to increase steroidogenesis
in the adrenal. Which of these is involved with increase in steroidogenesis in the
bovine and human adrenal cells needs to be determined. This can be tested by Gel
mobility shift assays in which supershifts are involved. Transcription factors that will
be examined include SF-1, AP-1 proteins, CREB, and STAT proteins.
Conclusion
The cytokine interleukin-6 is increased during physical and emotional stress.
IL-6 increases cortisol production in human and bovine adrenal cells. A possible
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mechanism by which IL-6 mediates this effect is through increasing the SF-1:DAX-1
ratio. The increase in this ratio would increase transcription of steroidogenic
enzymes and StAR. StAR is part of the rate limiting step in steroidogenesis.
Therefore, an increase in StAR would cause an increase in steroid production.
Likewise, an increase in all the enzymes involved in cortisol production would
increase steroid production. This research supports this hypothesis because IL-6
increased SF-1, known to be involved in transcription of steroidogenic genes in other
tissues, and decreased DAX-1, a transcription repressor. In contrast, the effect of IL6 on the bovine ZR tissue is opposite that of human H295R cells and bovine ZF
tissue. IL-6 decreases P450scc, 17α hydroxylase, 3β HSD2, 21 hydroxylase, 11β
hydroxylase, and StAR at the mRNA and protein levels. This effect may also be
mediated by the SF-1:DAX-1 ratio. IL-6 increased DAX-1 and decreased SF-1 in
this study. Therefore, IL-6 decreased the transcription activator, SF-1, and increased
the repressor, DAX-1. Consequently, during times of physical and emotional stress,
when IL-6 is elevated, cortisol would increase and androgen production would
decrease. This change in adrenal steroidogenesis would cause a suppression of the
immune system, increased anxiety, increased blood pressure, changes in metabolism,
and decreased bone formation. Therefore, by knowing how IL-6 regulates adrenal
steroidogenesis better treatments might be produced for patients suffering from
diseases which involve high levels of inflammation and stress.
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Fig. 1: Human Time and Dose Response SF-1 DAX-1, Standard PCR
Fig. 1A: Graph of SF-1 and DAX-1 in response to different concentrations of IL-6.
SF-1 increased1, 10, and 100 pg/ml IL-6. DAX-1 decreased significantly with 1, 10,
and 100 pg/ml IL-6. Fig. 1B: Graph of the ratio of SF-1:DAX-1 in response to
different concentrations of IL-6. The SF-1:DAX-1 ratio increase significantly with 1,
10, and 100 pg/ml Fig. 1C: Graph of SF-1 and DAX-1 mRNA in response to IL-6
dependent on time of incubation. SF-1 mRNA increased significantly after 120 min
of incubation with IL-6. DAX-1 mRNA decreased significantly by 30 min and
remained significantly decreased through 120 min. Fig. 1D: SF-1:DAX-1 mRNA
ratio in response to IL-6 and dependent on time of incubation. The SF-1:DAX-1 ratio
significantly increased at min after 100 min of incubation. Data was analyzed using
bonferroni test and a P value of 0.05. Data consists of 6 samples.
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Fig. 2: Human Time Course SF-1 DAX-1, Western Blot
Fig. 2A: Graph of the change in protein dependent on time of incubation with IL-6.
SF-1 protein increased significantly after 30 min of incubation time. SF-1 protein
remained significantly increased through 120 min. DAX-1 protein decreased
significantly after 30 min of incubation time and remained significantly decreased
through 120 min. Fig. 2B: graph of the change in SF-1:DAX-1 protein ratio. The
SF-1:DAX-1 protein ratio increased significantly by 30 min and remained
significantly increased through 120 min.
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Fig. 3: Bovine ZF Time Course SF-1 DAX-1, Western Blot
Fig. 3A: Graph of the change in SF-1 and DAX-1 protein dependent incubation time
with IL-6. Fig. 3B: Graph of the ratio of SF-1:DAX-1 protein. More data is needed
to determine if the change is significant.
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Fig. 4: Bovine ZF Dose ResponseSF-1 DAX-1, Western Blot
Fig. 4A: Graph of the change in SF-1 and DAX-1 protein dependent on the
concentration of IL-6. Fig. 4B: is a graph of the ratio of SF-1:DAX-1 protein
dependent on the concentration of IL-6. More data is needed to determine if the
change is significant.
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Fig. 5: Bovine ZR SF-1:DAX-1 Time Course, Western Blot
Fig. 5A: is a graph of the change in SF-1 and DAX-1 protein in response to different
time of incubation with IL-6. Fig. 5B: Graph of the change in the SF-1:DAX-1 ratio.
More data is needed to determine if the change in protein is significant.
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Fig. 6: Bovine ZR SF-1:DAX-1 Dose Response, Western Blot
Fig. 6A: Graph of the change in SF-1 and DAX-1 protein in response to different
concentration of IL-6. Fig. 6B: Graph of the change in the SF-1:DAX-1 ratio. More
data is needed to determine if the change in protein is significant.
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Fig. 7: Human Time Course StAR and enzymes, Standard PCR
Graph of the change in mRNA for StAR, P450scc, 17α hydroxylase, 3β HSD2, 21
hydroxylase, and 11β hydroxylase in human H295R cells incubated in medium
containing IL-6. StAR mRNA was significantly increased by 100 min. P450scc
mRNA significantly increased by 60 min and was not significantly increased by 100
min. 17α hydroxylase mRNA increased significantly by 100 min. 3β HSD2 was
significantly increased by 60 min and remained significantly increased through 100
min. 21 hydroxylase mRNA was significantly increased at 100 min of incubation.
11β hydroxylase increased significantly by 60 min and remained significantly
elevated through 100 min. Data was analyzed using the bonferroni test and a P value
of 0.05. Data consist of 6 samples.
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Fig. 8: Human Time Course StAR and enzymes, Western Blot
Graph of StAR, P450scc, 17α hydryoxylase, 21 hydroxylase, and 11β hydroxylase
protein levels in response to IL-6 and dependent on time of incubation. StAR protein
increased significantly at 10 min of incubation. By 30 min StAR was no longer
significantly increased. At 60 min StAR was increased significantly and remained
through 120 min. P450scc increased significantly by 60 min of incubation and
remained significantly elevated through 120 min. 17α hydroxylase protein increased
significantly by 30 min and remained significantly increased through 120min. 21
hydroxylase protein remained constant throughout the incubation period. No time
point was found to be significantly increased. 11β hydroxylase protein increased
significantly by 60 min and remained significantly increased through 120min. Data
was analyzed using bonferroni test with a P value of 0.05. Data consists of 6
samples.
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Fig. 9: Human Dose Response StAR and enzymes, Standard PCR
Graph of mRNA change for StAR, P450scc, and 3β HSD2 in response to different
concentrations of IL-6. StAR mRNA increased significantly with 10 and 100 pg/ml.
P450scc mRNA increased significantly with 1, 10, and 100 pg/ml. 3β HSD2 mRNA
increased significantly with 1, 10, and 100 pg/ml. Data was analyzed using the
bonferroni test with a P value of 0.05. Data consists of 6 samples.
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Fig. 10: Bovine ZF Time Course StAR and enzymes, Real Time PCR
Graph of the change in mRNA for StAR, P450scc, 17α hydroxylase, 3β HSD2, 21
hydroxylase, and 11β hydroxylase in bovine ZF tissue incubated with IL-6 containing
medium. StAR increased significantly at 30 min. At 80 and 140 min the change was
not significant. By 240 min StAR mRNA was again significantly increased. P450scc
mRNA was significantly increased by 80 min and remained elevated through 140
min. By 240 min P450scc mRNA was not significantly increased. 17α hydroxylase
mRNA increased significantly by 30 min and remained significantly elevated through
240 min. 3β HSD2 mRNA increased significantly by 30 min and remained through
80 min. By 140 min 3β HSD2 mRNA was no longer significantly increased. 21
hydroxylase increased significantly at 30 and 80 min. At 140 min of incubation 21
hydroxylase mRNA was not significantly increased. 11β hydroxylase increased
significantly only at 30 and 80 min of incubation. Data was analyzed using the
bonferroni test and a P valued of 0.05. Data consist of 8 samples.
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Fig. 11: Bovine ZF Dose Response StAR and enzymes, Real Time PCR
Graph of the change in mRNA for StAR, P450scc, 17α hydroxylase, 3β HSD2, 21
hydroxylase, and 11β hydroxylase. StAR mRNA was significantly increased with 1
but not 10 pg/ml IL-6. P450scc mRNA was significantly increased with 1 and 10
pg/ml IL-6. 17α hydroxylase was significantly increased by 1 and 10 pg/ml IL-6. 3β
HSD2 mRNA significantly increased with both 1 and 10 pg/ml. 21 hydroxylase
mRNA increased significantly with both 1 and 10 pg/ml. 11β hydroxylase mRNA
did not significantly increase with either concentration of IL-6. Data was analyzed
using the bonferroni test and a P value of 0.05. Data consists of 6 samples.
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Fig. 12: Bovine ZF Dose Response StAR and enzymes, Western Blot
Graph of the change in StAR, P450scc, 17α hydroxyase, 3β HSD2, and 11β
hydroxylase in response to different concentrations of IL-6. More data is needed to
determine if the changes are significant.
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Fig. 13: Bovine ZR Time Course StAR and enzymes, Real time PCR
Graph of the change in mRNA for StAR, P450scc, 17α hydroxylase, and 3β HSD2 in
bovine ZR tissue incubated with IL-6 containing medium. StAR mRNA decreased
significantly by 30 min and remained significantly decreased through 120 min.
P450scc mRNA also decreased significantly by 30 min and remained significantly
decreased through 120 min. 17α hydroxylase mRNA decreased significantly by 60
min and remained significantly decreased through 120 min. 3β HSD2 mRNA
decreased significantly within the first 10 min of incubation and remained
significantly decreased through 120 min. Data was analyzed using the bonferroni test
and a P value of 0.05. Data consist of 12 samples.
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Fig. 14: Bovine ZR Dose Response StAR and enzymes, Real Time PCR
Graph of the change in mRNA for StAR, P450scc, 17α hydroxylase, and 3β HSD2 in
bovine ZR tissue incubated in medium containing IL-6. StAR decreased significantly
in 10 and 100 pg/ml and maximal effect being reached with 100 pg/ml. P450scc also
decreased significantly with 10 and 100 pg/ml. The maximal decreased in P450scc
mRNA was reached with 100 pg/ml. 17α hydroxylase mRNA decrease significantly
with both 10 an 100 pg/ml with maximal effect reached with 100 pg/ml. 3β HSD2
mRNA decreased significantly with 1, 10, and 100 pg/ml. The maximal effect was
reached with 100 pg/ml. Data was analyzed using a bonferroni test and a P value of
0.05. Data consist of 8 samples.
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Fig. 15: Bovine ZR Dose Response StAR and enzymes, Western Blot
Graph of the change in protein, dependent on the concentration of IL-6, for StAR,
P450scc, 17α hydroxylase, 3β HSD2, and 11β hydroxylase. StAR protein decreased
significantly with 100 pg/ml IL-6. P450scc decreased significantly with 1,10, and
100 pg/ml. 17α hydroxylase decreased significantly with 1, 10, and 100 pg/ml IL-6.
3β HSD2 protein significantly decreased with 1, 10, and 100 pg/ml IL-6. Data was
analyzed using bonferroni test and a P value of 0.05. Data consist of 3 samples.
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Figure 16: Bovine ZF StAR Western Blot
The Bovine ZF tissue was treated with IL-6 containing serum free RPMI for time
intervals ranging from 10 – 90 min. The protein was then extracted from the tissue.
Western blot analysis was used to determine the effects of IL-6 as a function of time
on the StAR protein level. More data is needed to determine if the changes are
significant.
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Figure 17: Bovine ZR StAR Western Blot
The Bovine ZR tissue was treated with IL-6 containing serum free RPMI for time
intervals ranging from 30 – 240 min. The protein was then extracted from the tissue.
Western blot analysis was used to determine the effects of IL-6 as a function of time
on the StAR protein level. More data is needed to determine if the changes are
significant.
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Figure 18: Bovine ZF P450scc Western Blot
The Bovine ZF tissue was treated with IL-6, 50 pg/ml, containing serum free RPMI
for different time intervals. The protein was then extracted from the tissue. Western
analysis was used to determine the effects of IL-6 as a function of time on the
P450scc protein level. More data is needed to determine if the changes are
significant.
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Figure 19: Bovine ZR P450scc Western Blot
The Bovine ZR tissue was treated with IL-6 containing serum free RPMI for time
intervals ranging from 10 – 240 min. The protein was then extracted from the tissue.
Western blot analysis was used to determine the effects of IL-6 as a function of time
on the P450scc protein level. More data is needed to determine if the changes are
significant.
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Figure 20: Bovine 17α Hydroxylase Western Blot
Bovine ZF tissue was incubated in serum free RPMI containing 50 pg/ml IL-6 for
different time intervals. The tissue was lysed, and the protein was extracted. The
protein was then used for western blot analysis of the IL-6 effects on 17α hydroxylase
protein level as a function of time. More data is needed to determine if the changes
are significant.
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Figure 21: Bovine ZR 17α Hydroxylase Western Blot
Bovine ZR tissue was incubated in serum free medium containing 50 pg/ml IL-6 for
different time intervals. The tissue was lysed, and the protein was extracted. The
protein was then used for western blot analysis to determine the effects of IL-6 as a
function of time on 17α Hydroxylase protein. More data is needed to determine if the
changes are significant.
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Figure 22: Bovine ZF 3β HSD2 Western Blot
Bovine ZF Tissue was incubated in serum free RPMI containing 50 pg/ml IL-6 for
different time intervals. The tissue was lysed, and the protein was extracted. The
protein was then used for western blot analysis of the IL-6 effects on 3β HSD2
protein level as a function of time. More data is needed to determine if the changes
are significant.
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Fig. 23: Representation of the light emitted by SYBR green during the real time PCR
for 11β hydroxlyase ZF dose dependent (A) and time dependent (B) reactions.
B

A

Fig. 24: Representation of the light emitted by SYBR green during the real time PCR
for 21 hydroxylase ZF dose dependent (A) and time dependent (B) reactions.
B

A

Fig. 25: Representation of the light emitted by SYBR green during the real time PCR
for 3β HSD2 ZR dose dependent (A) and time dependent (B) reactions.
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Fig. 26: Representation of the light emitted by SYBR green during the real time PCR
for 3β HSD2 ZF dose dependent (A) and time dependent (B) reactions.
A

B

Fig. 27: Representation of the light emitted by SYBR green during the real time PCR
for 17α hydroxylase bovine ZR dose dependent (A) and time dependent (B) reactions.
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Fig. 28: Representation of the light emitted by SYBR green during the real time PCR
for 17α hydroxylase bovine ZF dose dependent (A) and time dependent (B)reactions.
A

B

Fig. 29: Representation of the light emitted by SYBR green during the real time PCR
for P450scc bovine ZR dose dependent (A) and time dependent (B) reactions.
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Fig. 30: Representation of the light emitted by SYBR green during the real time PCR
for P450scc bovine ZF dose dependent (A) and time dependent (B) reactions.
B

A

Fig. 31: Representation of the light emitted by SYBR green during the real time PCR
for StAR bovine ZR dose dependent (A) and time dependent (B) reactions.
B

A

Fig. 32: Representation of the light emitted by SYBR green during the real time PCR
for StAR bovine ZF dose dependent (A) and time dependent (B) reactions.
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Fig. 33: Melt Curves of the Real Time PCR Products
Fig. 31A: 11β hydroxylase bovine melt curve. Fig. 31B: 21 hydroxylase bovine
melt curve. Fig. 31C 3β HSD2 bovine melt curve Fig. 31D: 17α hydroxylase
bovine melt curve Fig. 31E: P450scc bovine melt curve Fig. 31F: StAR bovine melt
curve Fig. 31G: 18s bovine melt curve
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Diagram 1: Steroidogenic Pathway
Diagram of adrenal steroidogenic pathways and the enzymes involved (18).
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Diagram 2: PCR Temperatures and Times
Diagram of temperatures and cycles used for standard and real time PCR
thermocyclers. Different times and cycles were used for standard PCR than real time
PCR. Lower temperatures and times were used for real time PCR. Each primer had
an optimal annealing temperature.

Gene

Sequence

Strand

Human P450scc

GAGACCCATAGGAGTCCTGTTGAA

Anti-sense

AACCAGGAGGTGATGGCTCC

Sense

Table 1: Human primers used for real time PCR

Gene
Bovine StAR
Bovine P450scc
Bovine 17α
Hydroxylase

Sequence
TGGCATGGCCACACTCTATG
CCAGGTGAGTTTGGTCCTTGA
TCTCTTCAAGTTCGAGGGATCCT
CTCCAATGGGTTTCTGATAATATCG
TGTGGCCCCTACGCTGAT
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Strand
Sense
Anti-sense
Sense
Anti-sense
Sense

Bovine 3β HSD
Bovine 21
Hydroxylase
Bovine 11β
Hydroxylase

CAACGTCTGTGCCTTTGTCAAT
ACCAATCACTGCAAGTTCTCAAGA
GGCCCTCAAGGCCAGAAT
TGCCTTTCACGACTGTGTTCA

Anti-sense
Sense
Anti-sense
Sense

AAGAACCTGAGAAAAGGACCAATGT
GCGGCTTGGCCTTTTCA

Anti-sense
Sense

CAAAGTGCTCCCTCCACATGT

Anti-sense

Table 2: Bovine primers used for real time PCR
Gene

Sequence

Strand

Human DAX-1

AGGGGACCGTGCTCTTTAAC

Sense

ATGATGGGCCTGAAGAACAG

Anti-sense

GCAGAAGAAGGCACAGATTC

Sense

TGGGTACTCAGACTTGATGG

Anti-sense

CCAGATGTGGGCAAGGTG

Sense

CCTCTGCGCTTGGTACAGC

Anti-sense

CCTGCAGTGGCACTTGTATG

Sense

GGTCATCTCTAGCTCAGCGA

Anti-sense

CATGCTGGACACACTGATGC

Sense

CCTCCAGGCCTGGCGCACCT

Anti-sense

TGGAGCTGCCTTGTGACAGGA

Sense

CATCTGGAATCAAGGCGGAG

Anti-sense

TGCCTGCCTATTACAAATGT

Sense

GGTGAAGCAAAAAAACCACG

Anti-sense

TGCGCGTGTTCCTCTACTCT

Sense

AGAGACGTGATTAGTTGATG

Anti-sense

Human SF-1

Human StAR

Human P450scc

Human 17α
Hydroxylase
Human 3β HSD

Human 21 hydroxylase

Human 11β
Hydroxylase

Table 3: Human primers used for standard PCR
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Gene
Bovine DAX-1
Bovine SF-1
Bovine StAR
Bovine P450scc
Bovine 17α
Hydroxylase
Bovine 3β HSD
Bovine 21
Hydroxylase
Bovine 11β
Hydroxylase

Sequence
AGGGGACCGTGCTCTTTAAC
ATGATGGGCCTGAAGAACAG
GCAGAAGAAGGCACAGATTC
TGGGTACTCAGACTTGATGG
CCTCTCTACAGCGACCAA
TCGTGAGTGATGACCGTG
AACGTCCCTCCAGAACTGTACC
CTTGCTTATGTCTCCCTCTGCC
TACTGATCCAAGCCAAGGTG

Strand
Sense
Anti-sense
Sense
Anti-sense
Sense
Anti-sense
Sense
Anti-sense
Sense

GCGCACCTCGATCTTCAC
GGCCGTCTTGGATGATCT
CGTGACCATCCAGAAGGAAT

Anti-sense
Sense
Anti-sense
Sense

GGTGAAGTAGGAACGCCACA
ACGCTGGTGAAGGTCCTACT

Anti-sense
Sense

TCAGGGCTCGTAGGAGAAAA

Anti-sense

Table 4: Bovine primers used for standard PCR
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